AKHOMM initiative curriculum and learning and action collaborative

被引:0
作者
Calvin, J. Meaney [1 ]
Hudson, Joanna Q. [2 ]
Bowman, Brendan [3 ]
Traynor, Andrew [4 ]
机构
[1] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharm Practice, Div Outcomes & Practice Advancement, Buffalo, NY 14214 USA
[2] Univ Tennessee Hlth Sci Ctr, Coll Pharm, Dept Clin Pharm & Translat Sci, Memphis, TN USA
[3] Univ Virginia Hlth, Div Med Nephrol, DaVita Kidney Care, Charlottesville, VA USA
[4] Univ Minnesota, Coll Pharm, Minneapolis, MN USA
关键词
comprehensive medication management; kidney diseases; medication therapy management; professional education; IMPLEMENTATION;
D O I
10.1093/ajhp/zxaf046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose The Advancing Kidney Health through Optimal Medication Management (AKHOMM) initiative was developed with the vision that every person with kidney disease receives optimal medication management through team-based care including a pharmacist to improve kidney health. Due to the need for education and clinical practice implementation strategies, the AKHOMM initiative designed 2 educational programs to help achieve our vision: a continuing education curriculum and a learning and action collaborative (LAC).Summary The curriculum is online, interactive, and case based, with interprofessional accreditation, to provide baseline competency in comprehensive medication management (CMM) across chronic kidney disease and address health disparities in this population. The development process involved an interprofessional approach with input from persons with kidney disease and care partners. Modules have been well received based on postactivity surveys, with over 90% of respondents (970/1,044) indicating that the activity will improve their ability to treat and manage their patients. Ongoing quality assurance of existing modules, coupled with development of new modules in prioritized areas (cardiovascular-kidney-metabolic [CKM] syndrome, glomerular diseases) will continue to provide education to the pharmacy and broader healthcare communities. The LAC was designed using implementation science principles to facilitate pharmacist inclusion in patient care teams to provide CMM to patients with CKM. Site teams will include a pharmacist, provider champion, and others coupled with an implementation coach and field expert. Through a continuous quality improvement framework, the teams will work towards achieving their bold aim over a 12-month implementation period.Conclusion The curriculum and LAC address the current void of pharmacist-based care in CKM.
引用
收藏
页码:719 / 724
页数:6
相关论文
共 10 条
[1]  
Advancing Kidney Health through Optimal Medication Management, US
[2]   Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review [J].
Al Raiisi, Fatma ;
Stewart, Derek ;
Fernandez-Llimos, Fernando ;
Salgado, Teresa M. ;
Mohamed, Moustafa Fahmy ;
Cunningham, Scott .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (03) :630-666
[3]   Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) [J].
de Boer, Ian H. ;
Khunti, Kamlesh ;
Sadusky, Tami ;
Tuttle, Katherine R. ;
Neumiller, Joshua J. ;
Rhee, Connie M. ;
Rosas, Sylvia E. ;
Rossing, Peter ;
Bakris, George .
DIABETES CARE, 2022, 45 (12) :3075-3090
[4]   Measuring implementation of medication optimization services: Development and validation of an implementation outcomes questionnaire [J].
Livet, Melanie ;
Blanchard, Carrie ;
Richard, Chloe ;
Sheppard, Kelly ;
Yannayon, Mary ;
Sorensen, Todd ;
McClurg, Mary Roth .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (09) :1623-1630
[5]   Ensuring effective implementation: A fidelity assessment system for comprehensive medication management [J].
Livet, Melanie ;
Blanchard, Carrie ;
Frail, Caity ;
Sorensen, Todd ;
McClurg, Mary R. .
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2020, 3 (01) :57-67
[6]  
Livet M, 2018, J AM COLL CLIN PHARM, V1, P14, DOI 10.1002/jac5.1037
[7]   Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association [J].
Ndumele, Chiadi E. ;
Rangaswami, Janani ;
Chow, Sheryl L. ;
Neeland, Ian J. ;
Tuttle, Katherine R. ;
Khan, Sadiya S. ;
Coresh, Josef ;
Mathew, Roy O. ;
Baker-Smith, Carissa M. ;
Carnethon, Mercedes R. ;
Despres, Jean-Pierre ;
Ho, Jennifer E. ;
Joseph, Joshua J. ;
Kernan, Walter N. ;
Khera, Amit ;
Kosiborod, Mikhail N. ;
Lekavich, Carolyn L. ;
Lewis, Eldrin F. ;
Lo, Kevin B. ;
Ozkan, Bige ;
Palaniappan, Latha P. ;
Patel, Sonali S. ;
Pencina, Michael J. ;
Powell-Wiley, Tiffany M. ;
Sperling, Laurence S. ;
Virani, Salim S. ;
Wright, Jackson T. ;
Singh, Radhika Rajgopal ;
Elkind, Mitchell S. V. ;
Amer Heart Assoc .
CIRCULATION, 2023, 148 (20) :1606-1635
[8]  
Pestka Deborah L, 2021, Innov Pharm, V12, DOI 10.24926/iip.v12i1.3610
[9]   The Intersection of Implementation Science and Pharmacy Practice Transformation [J].
Smith, Marie A. ;
Blanchard, Carrie Martin ;
Vuernick, Erika .
ANNALS OF PHARMACOTHERAPY, 2020, 54 (01) :75-81
[10]   KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE EVALUATION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE [J].
Stevens, Paul E. ;
Ahmed, Sofia B. ;
Carrero, Juan Jesus ;
Foster, Bethany ;
Francis, Anna ;
Hall, Rasheeda K. ;
Herrington, Will G. ;
Hill, Guy ;
Inker, Lesley A. ;
Kazancio, Rumeyza ;
Lamb, Edmund ;
Lin, Peter ;
Levin, Adeera .
KIDNEY INTERNATIONAL, 2024, 105 (04) :S117-S117